The stock of Akers Biosciences Inc (NASDAQ:AKER) is a huge mover today! About 264,869 shares traded hands or 606.58% up from the average. Akers Biosciences Inc (NASDAQ:AKER) has risen 17.65% since April 20, 2016 and is uptrending. It has outperformed by 13.09% the S&P500.
The move comes after 7 months positive chart setup for the $9.81 million company. It was reported on Nov, 22 by Barchart.com. We have $2.19 PT which if reached, will make NASDAQ:AKER worth $686,700 more.
According to Zacks Investment Research, “Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company’s products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.”
More recent Akers Biosciences Inc (NASDAQ:AKER) news were published by: Quotes.Wsj.com which released: “News Akers Biosciences Inc.AKER” on January 24, 2014. Also Marketwatch.com published the news titled: “Akers Biosciences halves loss; revenue up 262%” on November 14, 2016. Finance.Yahoo.com‘s news article titled: “Akers Biosciences Announces Q3 Earnings” with publication date: November 14, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.